Plasmapheresis in Refractory Generalized Myasthenia Gravis
- 1 August 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (8) , 478-481
- https://doi.org/10.1001/archneur.1981.00510080040003
Abstract
• A group of 16 patients with severe generalized myasthenia gravis (MG) (five with thymoma) that was resistant to anticholinesterases, thymectomy, and corticosteroids were treated by plasmapheresis. Twelve patients showed an excellent clinical response. Plasmapheresis is an effective treatment modality for many patients with severe generalized MG resistant to other forms of therapy. Unfortunately, the beneficial results are only transient and periodic plasmapheresis treatments are necessary.This publication has 6 references indexed in Scilit:
- Plasmapheresis therapy in myasthenia gravisMuscle & Nerve, 1980
- Antireceptor-Antibody Decline Without Improvement After Plasmapheresis in Myasthenia GravisAnnals of Internal Medicine, 1980
- PLASMA-EXCHANGE COMBINED WITH IMMUNOSUPPRESSIVE THERAPY IN MYASTHENIA GRAVISThe Lancet, 1979
- Function of circulating antibody to acetylcholine receptor in myasthenia gravisNeurology, 1978
- Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia GravisNew England Journal of Medicine, 1977
- Detection of Anti-Acetylcholine Receptor Factors in Serum and Thymus from Patients with Myasthenia GravisNew England Journal of Medicine, 1976